Correlation Between Quoin Pharmaceuticals and Synlogic

Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Synlogic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Synlogic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Synlogic, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Synlogic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Synlogic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Synlogic.

Diversification Opportunities for Quoin Pharmaceuticals and Synlogic

0.36

Correlation Coefficient

Quoin Pharmaceuticals  Synlogic

Weak diversification

The 3 months correlation between Quoin and Synlogic is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Synlogic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synlogic and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Synlogic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synlogic has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Synlogic go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and Synlogic

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Synlogic. In addition to that, Quoin Pharmaceuticals is 3.49 times more volatile than Synlogic. It trades about -0.12 of its total potential returns per unit of risk. Synlogic is currently generating about -0.02 per unit of volatility. If you would invest  137.00  in Synlogic on December 19, 2024 and sell it today you would lose (6.00) from holding Synlogic or give up 4.38% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Quoin Pharmaceuticals Ltd  vs.  Synlogic

Quoin Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Quoin Pharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Synlogic

Risk-Adjusted Performance

Very Weak

Over the last 90 days Synlogic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Synlogic is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Quoin Pharmaceuticals and Synlogic

The main advantage of trading using opposite Quoin Pharmaceuticals and Synlogic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Synlogic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synlogic will offset losses from the drop in Synlogic's long position.

The idea behind Quoin Pharmaceuticals Ltd and Synlogic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.